Kera Capital Partners Inc. Has $787,000 Stake in Molina Healthcare, Inc $MOH

Kera Capital Partners Inc. grew its stake in Molina Healthcare, Inc (NYSE:MOH) by 432.5% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,111 shares of the company’s stock after buying an additional 3,339 shares during the period. Kera Capital Partners Inc.’s holdings in Molina Healthcare were worth $787,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in MOH. Invesco Ltd. lifted its holdings in Molina Healthcare by 25.9% in the 2nd quarter. Invesco Ltd. now owns 1,601,574 shares of the company’s stock worth $477,109,000 after purchasing an additional 329,759 shares during the last quarter. AQR Capital Management LLC raised its position in shares of Molina Healthcare by 4.6% in the second quarter. AQR Capital Management LLC now owns 925,672 shares of the company’s stock valued at $273,096,000 after purchasing an additional 40,714 shares during the period. Norges Bank acquired a new stake in shares of Molina Healthcare in the second quarter worth $212,113,000. Charles Schwab Investment Management Inc. lifted its stake in shares of Molina Healthcare by 0.8% in the second quarter. Charles Schwab Investment Management Inc. now owns 419,457 shares of the company’s stock worth $124,956,000 after buying an additional 3,216 shares during the last quarter. Finally, Bank of New York Mellon Corp boosted its holdings in shares of Molina Healthcare by 8.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 364,716 shares of the company’s stock worth $108,649,000 after buying an additional 28,562 shares during the period. Institutional investors and hedge funds own 98.50% of the company’s stock.

Molina Healthcare Trading Down 0.5%

Shares of NYSE MOH opened at $180.92 on Wednesday. Molina Healthcare, Inc has a 1-year low of $133.40 and a 1-year high of $359.97. The company has a market cap of $9.81 billion, a PE ratio of 11.20 and a beta of 0.49. The company has a current ratio of 1.68, a quick ratio of 1.68 and a debt-to-equity ratio of 0.92. The company has a 50-day moving average of $158.06 and a two-hundred day moving average of $175.75.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Wednesday, October 22nd. The company reported $1.84 EPS for the quarter, missing the consensus estimate of $3.97 by ($2.13). Molina Healthcare had a net margin of 1.98% and a return on equity of 22.95%. The company had revenue of $11.48 billion for the quarter, compared to the consensus estimate of $10.99 billion. During the same period last year, the company earned $6.01 earnings per share. Molina Healthcare’s revenue for the quarter was up 11.0% compared to the same quarter last year. Molina Healthcare has set its FY 2025 guidance at 14.000-14.000 EPS. As a group, equities analysts expect that Molina Healthcare, Inc will post 24.4 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

MOH has been the subject of a number of research analyst reports. Barclays boosted their target price on shares of Molina Healthcare from $144.00 to $164.00 and gave the stock an “underweight” rating in a research report on Monday, January 5th. Deutsche Bank Aktiengesellschaft set a $165.00 price objective on Molina Healthcare in a research report on Friday, October 24th. Sanford C. Bernstein reissued an “outperform” rating and issued a $224.00 target price on shares of Molina Healthcare in a research note on Tuesday, January 6th. Wells Fargo & Company increased their target price on Molina Healthcare from $165.00 to $208.00 and gave the stock an “overweight” rating in a report on Wednesday, January 7th. Finally, TD Cowen cut Molina Healthcare from a “buy” rating to a “hold” rating and set a $203.00 price objective for the company. in a report on Thursday, October 16th. Three research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, Molina Healthcare has a consensus rating of “Hold” and an average target price of $193.47.

Insider Activity

In related news, Director Richard M. Schapiro sold 357 shares of the firm’s stock in a transaction dated Monday, November 24th. The stock was sold at an average price of $143.02, for a total value of $51,058.14. Following the transaction, the director owned 11,352 shares in the company, valued at $1,623,563.04. This trade represents a 3.05% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.26% of the stock is owned by company insiders.

Molina Healthcare Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.